Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
We describe the annual incidence of primary bloodstream infection (BSI) associated with Candida albicans and common non-albicans species of Candida among patients in intensive care units that participated in the National Nosocomial Infections Surveillance system from 1 January 1989 through 31 December 1999. During the study period, there was a significant decrease in the incidence of C. albicans BSI (P<.001) and a significant increase in the incidence of Candida glabrata BSI (P=.05).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there was a statistically significant increase in the rate of infections due to Candida glabrata, which is now the second most common cause of bloodstream and mucosal infections in the United States (6, 48, 65, 69).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [65]
In the citing paper
“there was a significant decrease in the annual incidence of infections with Candida albicans, the most common cause of Candida BSI, in this group of patients in the 1990s (40).”
In the citing paper
“During the same time period, there was a significant increase in the incidence of C. glabrata BSI (40).”
In the citing paper
“Although C. albicans continues to be the single most common species causing candidemia, results from this study confirm prior reports that, compared to the situation in the 1980s, a larger proportion of Candida BSI in the United States is now caused by Candida species other than C. albicans (20, 40).”
In the citing paper
“A significant increase in C. glabrata BSI was also noted (from 0.2 per 10,000 CVC days in 1989 to 0.5 per 10,000 CVC days in 1999; P = 0.05)”
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Self-citationEpidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782
Self-citation1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 672
Self-citationNosocomial infection rates in adult and pediatric intensive care units in the United States
Jarvis, W. R., Edwards, J. R., Culver, D. H., Hughes, J. M., Horan, T., Emori, T. G., Banerjee, S., Tolson, J., Henderson, T., Gaynes, R. P., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90367-7 · Cited by 497
Self-citationKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Self-citationKomshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369
Research works printed but not linked: 3
- Jarvis WR, 1991, National Nosocomial Infections Surveillance System. Am J Med, 91, 185S
- 10.1001/archinte.149.10.2349 · DOI · Paper page
- National Nosocomial Infections Surveillance, 2000, MMWR Morb Mortal Wkly Rep, 49, 149
Cited by
Items 201–300 of 664
Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
Ranjbar, R., Izadi, M., Hafshejani, T. T., & Khamesipour, F. (2016) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2015.12.012 · Cited by 59
Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
Patel, M., Kunz, D. F., Trivedi, V. M., Jones, M. G., Moser, S. A., & Baddley, J. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.010 · Cited by 58
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7‐year period
Schelenz, S., & Gransden, W. R. (2003) · Mycoses · doi:10.1046/j.0933-7407.2003.00907.x · Cited by 56
Molecular Mechanisms of Resistance to 5-Fluorocytosine in Laboratory Mutants of Candida glabrata
Vandeputte, P., Pineau, L., Larcher, G., Noel, T., Brèthes, D., Chabasse, D., & Bouchara, J.-P. (2011) · Mycopathologia · doi:10.1007/s11046-010-9342-1 · Cited by 55
Epidemiology of Community‐Onset Candidemia in Connecticut and Maryland
Sofair, A. N., Lyon, G. M., Huie‐White, S., Reiss, E., Harrison, L. H., Sanza, L. T., Arthington‐Skaggs, B. A., & Fridkin, S. K. (2006) · Clinical Infectious Diseases · doi:10.1086/504807 · Cited by 54
Self-citationCandida glabrata fungaemia in intensive care units
Ruan, S., Lee, L., Jerng, J., Yu, C., & Hsueh, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01892.x · Cited by 59
Zaoutis, T. E., Foraker, E., McGowan, K. L., Mortensen, J. E., Campos, J. M., Walsh, T. J., & Klein, J. D. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.03.002 · Cited by 59
Rodríguez-Pardo, D., the Barcelona Candidemia Project Study Group, Almirante, B., Cuenca‐Estrella, M., Rodríguez-Tudela, J. L., Mensa, J., Ayats, J., Sánchez, F., & Pahissa, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03208.x · Cited by 60
Candidemia: The Impact of Antifungal Prophylaxis in a Surgical Intensive Care Unit
Swoboda, S. M., Merz, W. G., & Lipsetta, P. A. (2003) · Surgical Infections · doi:10.1089/109629603322761409 · Cited by 54
Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01318.x · Cited by 65
Practices in non-neutropenic ICU patients with Candida-positive airway specimens
Azoulay, É., Cohen, Y., Zahar, J., Garrouste-Orgeas, M., Adrie, C., Moine, P., de Lassence, A., & Timsit, J. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2316-3 · Cited by 57
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 63
Ellepola, A. N. B., Hurst, S. F., Elie, C. M., & Morrison, C. J. (2003) · Oral Microbiology and Immunology · doi:10.1046/j.0902-0055.2003.00103.x · Cited by 64
UPC2A Is Required for High-Level Azole Antifungal Resistance in Candida glabrata
Whaley, S. G., Caudle, K. E., Vermitsky, J.-P., Chadwick, S. G., Toner, G., Barker, K. S., Gygax, S. E., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02217-13 · Cited by 52
Diagnostic challenges and recent advances in the early management of invasive fungal infections
Chandrasekar, P. H. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01391.x · Cited by 55
Lagrou, K., Verhaegen, J., Peetermans, W. E., Rijdt, T. D., Maertens, J. A., & Wijngaerden, E. V. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0339-8 · Cited by 63
Jawhara, S., Mogensen, E., Maggiotto, F., Fradin, C., Sarazin, A., Dubuquoy, L., Maes, E., Guérardel, Y., Janbon, G., & Poulain, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329300 · Cited by 51
Antimicrobial treatment for intra-abdominal infections
Mazuski, J. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.17.2933 · Cited by 51
Treatment of Candida infection: a view from the trenches!
Bustamante, C. I. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000191516.43792.61 · Cited by 51
Surgical critical care: Fungal infections in surgical patients
Lipsett, P. A. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000231883.93001.e0 · Cited by 52
Carver, P. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d301 · Cited by 51
Candidemia surveillance in Iowa: emergence of echinocandin resistance
Matsumoto, E., Boyken, L., Tendolkar, S., McDanel, J., Castanheira, M., Pfaller, M., & Diekema, D. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.02.016 · Cited by 50
Playford, E. G., Nimmo, G. R., Tilse, M. H., & Sorrell, T. C. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.01.022 · Cited by 50
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Xie, G.-H., Fang, X.-M., Fang, Q., Wu, X.-M., Jin, Y.-H., Wang, J.-L., Guo, Q.-L., Gu, M.-N., Xu, Q.-P., Wang, D.-X., et al. (2008) · Critical Care · doi:10.1186/cc6766 · Cited by 49
Emerging echinocandins for treatment of invasive fungal infections
Turner, M. S., Drew, R. H., & Perfect, J. R. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.2.231 · Cited by 49
Harnessing the power of fungal siderophores for the imaging and treatment of human diseases
Szebesczyk, A., Olshvang, E., Shanzer, A., Carver, P. L., & Gumienna‐Kontecka, E. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.05.001 · Cited by 55
Invasive Fungal Infections and Their Epidemiology: Measures in the Clinical Scenario
Bajpai, V. K., Khan, I., Shukla, S., Kumar, P., Rather, I. A., Park, Y.-H., Huh, Y. S., & Han, Y. (2019) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-018-0477-0 · Cited by 62
Trivedi, H., Desai, K. J., Trivedi, L., Malek, S. S., & Javdekar, T. B. (2011) · National journal of integrated research in medicine · Cited by 47
Nisin Z inhibits the growth ofCandida albicansand its transition from blastospore to hyphal form
Lay, C., Akerey, B., Fliss, I., Subirade, M., & Rouabhia, M. (2008) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03908.x · Cited by 50
Aspartic Protease Inhibitors: Effective Drugs against the Human Fungal Pathogen Candida albicans
dos Santos, A. L. S., & Braga-Silva, L. A. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955713804484802 · Cited by 47
Angoulvant, A., Guitard, J., & Hennequin, C. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov114 · Cited by 67
Is Candida really a threat in the ICU?
Blot, S. I., Dimopoulos, G., Rello, J., & Vogelaers, D. (2008) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32830f1dff · Cited by 49
Human genetic susceptibility to Candida infections
Plantinga, T. S., Johnson, M. D., Scott, W. K., Joosten, L. A. B., van der Meer, J. W. M., Perfect, J. R., Kullberg, B. J., & Netea, M. G. (2012) · Medical Mycology · doi:10.3109/13693786.2012.690902 · Cited by 47
Safdar, A., Chaturvedi, V., Koll, B. S., Larone, D. H., Perlin, D. S., & Armstrong, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3268-3272.2002 · Cited by 46
yKu70/yKu80 and Rif1 Regulate Silencing Differentially at Telomeres in Candida glabrata
Rosas-Hernández, L. L., Juárez-Reyes, A., Arroyo-Helguera, O. E., De Las Peñas, A., Pan, S.-J., Cormack, B. P., & Castaño, I. (2008) · Eukaryotic Cell · doi:10.1128/ec.00228-08 · Cited by 45
Clinical Trials of Antifungal Prophylaxis among Patients Undergoing Surgery
Calandra, T., & Marchetti, O. (2004) · Clinical Infectious Diseases · doi:10.1086/421955 · Cited by 47
Liu, J., Bolstad, D. B., Smith, A. E., Priestley, N. D., Wright, D. L., & Anderson, A. C. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.07.013 · Cited by 44
Zhang, X., Gu, B., Mei, Y., Wen, Y., & Xia, W. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.119 · Cited by 45
Moonlight-like proteins of the cell wall protect sessile cells of Candida from oxidative stress
Serrano‐Fujarte, I., López-Romero, E., & Cuéllar‐Cruz, M. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.10.001 · Cited by 49
Treatment of Candiduria with Micafungin: A Case Series
Lagrotteria, D., Rotstein, C., & Lee, C. H. (2007) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2007/768734 · Cited by 44
Vetiver Essential Oil in Cosmetics: What Is New?
Burger, P., Landreau, A., Watson, M., Janci, L., Cassisa, V., Kempf, M., Azoulay, S., & Fernàndez, X. (2017) · Medicines · doi:10.3390/medicines4020041 · Cited by 57
The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis
Ho, K. M., Lipman, J., Dobb, G. J., & Webb, S. A. (2005) · Critical Care · doi:10.1186/cc3883 · Cited by 43
Zilberberg, M. D., & Shorr, A. F. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.008 · Cited by 42
How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation
Jawhara, S. (2022) · Microorganisms · doi:10.3390/microorganisms10051014 · Cited by 57
Candida albicans: Molecular interactions with Pseudomonas aeruginosa and Staphylococcus aureus
Lindsay, A. K., & Hogan, D. A. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.10.002 · Cited by 53
No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011
Meyer, E., Geffers, C., Gastmeier, P., & Schwab, F. (2013) · Eurosurveillance · doi:10.2807/ese.18.24.20505-en · Cited by 42
Playford, E. G., Eggimann, P., & Calandra, T. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283177967 · Cited by 46
Candida glabrata strain relatedness by new microsatellite markers
Abbes, S., Sellami, H., Sellami, A., Hadrich, I., Amouri, I., Mahfoudh, N., Néji, S., Makni, F., Makni, H., & Ayadi, M. A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1280-4 · Cited by 47
Prophylaxis, empirical and preemptive treatment of invasive candidiasis
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e10e8 · Cited by 41
ElFeky, D. S., Gohar, N. M., El-Seidi, E. A., Ezzat, M. M., & AboElew, S. H. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.10.001 · Cited by 76
Zhang, X.-B., Yu, S.-J., Yu, J.-X., Gong, Y.-L., Feng, W., & Sun, F.-J. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.510 · Cited by 41
Prediction of invasive candidal infection in critically ill patients with severeacute pancreatitis
Hall, A., Poole, L., Renton, B., Wozniak, A., Fisher, M., Neal, T. J., Halloran, C. M., Cox, T. F., & Hampshire, P. A. (2013) · Critical Care · doi:10.1186/cc12569 · Cited by 44
Cuéllar-Cruz, M., Castaño, I., Arroyo-Helguera, O., & De Las Peñas, A. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000400020 · Cited by 41
Zilberberg, M. D., Kothari, S., & Shorr, A. F. (2009) · Critical Care · doi:10.1186/cc7924 · Cited by 41
Recommendations for the management of candidemia in adults in Latin America
Nucci, M., Thompson-Moya, L., Guzman-Blanco, M., Tiraboschi, I. N., Cortes, J. A., Echevarría, J., Sifuentes, J., Zurita, J., Santolaya, M. E., Alvarado Matute, T., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.007 · Cited by 41
Passos, X. S., Costa, C. R., de Araújo, C. R., Nascimento, E. S., Souza, L. K. H. E., Fernandes, O. D. F. L., Sales, W. S., & Silva, M. D. R. R. (2007) · Mycopathologia · doi:10.1007/s11046-007-0094-5 · Cited by 52
Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital
Yapar, N., Uysal, U., Yucesoy, M., Cakir, N., & Yuce, A. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01187.x · Cited by 41
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Horn, D. L., Neofytos, D., Pfaller, M. A., & Diekema, D. J. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.007 · Cited by 43
Das, S., Brown, T. M., Kellar, K. L., Holloway, B. P., & Morrison, C. J. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2005.00031.x · Cited by 41
Effect of progesterone on Candida albicans vaginal pathogenicity
Alves, C. T., Silva, S. M., Pereira, L., Williams, D. W., Azeredo, J., & Henriques, M. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.07.004 · Cited by 50
Voriconazole for serious fungal infections
Gothard, P., & Rogers, T. R. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.0099.x · Cited by 40
Berdal, J., Haagensen, R., Ranheim, T. E., & Bjørnholt, J. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103916 · Cited by 46
Epidemiology of opportunistic invasive fungal infections in China: review of literature
Liao, Y., Chen, M., Hartmann, T., Yang, R., & Liao, W. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20121945 · Cited by 42
A one-year survey of candidemia in Belgium in 2002
SWINNE, D., WATELLE, M., SUETENS, C., MERTENS, K., FONTEYNE, P.-A., & NOLARD, N. (2004) · Epidemiology and Infection · doi:10.1017/s095026880400295x · Cited by 39
Enache-Angoulvant, A., Bourget, M., Brisse, S., Stockman-Pannier, C., Diancourt, L., François, N., Rimek, D., Fairhead, C., Poulain, D., & Hennequin, C. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02140-09 · Cited by 38
The predictors of outcome in immunocompetent patients with hematogenous candidasis
Safdar, A., Bannister, T. W., & Safdar, Z. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.05.003 · Cited by 38
Invasive candidiasis and candidemia: from current opinions to future perspectives
Rüping, M., Vehreschild, J. J., & Cornely, O. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902911440 · Cited by 48
Kale‐Pradhan, P. B., Morgan, G., Wilhelm, S. M., & Johnson, L. B. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.12.1207 · Cited by 37
Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality
Bader, M. S., Lai, S. M., Kumar, V., & Hinthorn, D. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021126 · Cited by 37
Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors
Boo, T. W., O'Reilly, B., O'Leary, J., & Cryan, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01134.x · Cited by 37
Fungal Infections: Their Diagnosis and Treatment in Transplant Recipients
Thiel, D. H. V., George, M., & Moore, C. M. (2012) · International Journal of Hepatology · doi:10.1155/2012/106923 · Cited by 39
Fungal infections in severe acute pancreatitis
Kochhar, R. K., Noor, M. T., & Wig, J. D. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06685.x · Cited by 38
Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France
Richaud, C., LASTOURS, V. D., Panhard, X., Petrover, D., Fantin, B., & Lefort, A. (2017) · Medicine · doi:10.1097/md.0000000000007525 · Cited by 42
Urea Amidolyase (DUR1,2) Contributes to Virulence and Kidney Pathogenesis of Candida albicans
Navarathna, D. H. M. L. P., Lionakis, M. S., Lizak, M. J., Munasinghe, J., Nickerson, K. W., & Roberts, D. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048475 · Cited by 41
Candidemia in the 21st Century
Chang, A., Neofytos, D., & Horn, D. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.463 · Cited by 44
Gonzalez, G. M., Trevino-Rangel, R. D. J., Palma-Nicolas, J. P., Martinez, C., Gonzalez, J. G., Ayala, J., Caballero, A., Morfin-Otero, R., Rodriguez-Noriega, E., Velarde, F., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt283 · Cited by 35
Evaluation of intravenous voriconazole in patients with compromised renal function
Lilly, C. M., Welch, V., Mayer, T., Ranauro, P. J., Meisner, J., & Luke, D. R. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-14 · Cited by 38
Increase in Candida parapsilosis Fungemia in Critical Care Units: A 6-Years Study
Horasan, E. Ş., Ersöz, G., GÖKSU, M., Otaǧ, F., Kurt, A., Karaçorlu, S., & Ali Hakan, K. A. Y. A. (2010) · Mycopathologia · doi:10.1007/s11046-010-9322-5 · Cited by 40
Infections in Intestinal and Multivisceral Transplant Recipients
Timpone, J. G., Girlanda, R., Rudolph, L., & Fishbein, T. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.02.012 · Cited by 35
McTaggart, L. R., Cabrera, A. L., Cronin, K. I., & Kus, J. V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-20 · Cited by 39
Candidemia in Burn Patients: Figures and Facts
Pedrosa, A. F., & Rodrigues, A. G. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f2d4fb · Cited by 37
Ellepola, A. N. B., Khan, Z. U., Joseph, B. K., Chandy, R. G., & Philip, L. (2011) · Medical Principles and Practice · doi:10.1159/000323440 · Cited by 41
Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital
Sabino, R., Veríssimo, C., Brandão, J. C., Alves, C., Parada, H., Rosado, L., Paixão, E., Videira, Z., Tendeiro, T. C., Sampaio, P., et al. (2009) · Medical Mycology · doi:10.3109/13693780903161216 · Cited by 45
Recommendations for the management of candidemia in children in Latin America
Santolaya, M. E., Telles, F. D. Q., Matute, T. A., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.010 · Cited by 38
Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital
Luzzati, R., Allegranzi, B., Antozzi, L., Masala, L., Pegoraro, E., Azzini, A., & Concia, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01268.x · Cited by 33
Liu, C., Liao, C., Chen, Y., & Chang, S. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60065-5 · Cited by 33
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · Candida and Candidiasis · doi:10.1128/9781555817176.ch29 · Cited by 33
Cascio, G. L., Koncan, R., Stringari, G., Russo, A., Azzini, A. M., Ugolini, A., Ligozzi, M., Polati, E., Cornaglia, G., Concia, E., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2239-z · Cited by 35
The inhibitory effects of aureobasidin A on Candida planktonic and biofilm cells
Tan, H. W., & Tay, S. T. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02225.x · Cited by 33
Metwally, L. A., Hogg, G., Coyle, P. V., Hay, R. J., Hedderwick, S. A., McCloskey, B., O’Neill, H. J., Ong, G., Thompson, G., Webb, C. H., et al. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47149-0 · Cited by 33
Rapid identification of Candida glabrata in Candida bloodstream infections
Foster, N., Symes, C., Barton, R., & Hobson, R. P. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47406-0 · Cited by 36
Xu, J., Luo, Y., Wang, J., Tu, W., Yi, X., Xu, X., Song, Y., Tang, Y., Hua, X., Yu, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125676 · Cited by 48
Antifungal Susceptibility of Bloodstream Candida Isolates in Sfax Hospital: Tunisia
Sellami, A., Sellami, H., Néji, S., Makni, F., Abbes, S., Cheikhrouhou, F., Chelly, H., Bouaziz, M., Hammami, B., Jemâa, M. B., et al. (2010) · Mycopathologia · doi:10.1007/s11046-010-9388-0 · Cited by 36
Guitard, J., Tabone, M., Senghor, Y., Cros, C., Moissenet, D., Markowicz, K., Valin, N., Leverger, G., & Hennequin, C. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.007 · Cited by 35
Nace, H., Horn, D., & Neofytos, D. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.010 · Cited by 41
Bertagnolio, S., Donati, K. D. G., Tacconelli, E., Scoppettuolo, G., Posteraro, B., Fadda, G., Cauda, R., & Tumbarello, M. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.2.172 · Cited by 34
Lipsett, P. A. (2004) · Clinical Infectious Diseases · doi:10.1086/421956 · Cited by 32
Candidaemia in a large teaching hospital: a clinical audit
Aliyu, S. H. (2006) · QJM · doi:10.1093/qjmed/hcl087 · Cited by 31
Metadata
- Authors
- Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09
- Volume
- 35
- Issue
- 5
- Pages
- 627-630
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2121025359
- Cited by
- 660
- References
- 19
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 13 · 2016: 23 · 2015: 34 · 2014: 31 · 2013: 32 · 2012: 32
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- Candida albicans, Candida glabrata, non-albicans Candida, bloodstream infection, intensive care unit patients, nosocomial infections, incidence trends, National Nosocomial Infections Surveillance System
- MeSH terms
- Adult, Candida, Candidiasis, Cross Infection, Female, Humans, Intensive Care Units, Male, Middle Aged, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.